Los Angeles Capital Management LLC Dexcom Inc Transaction History

Los Angeles Capital Management LLC

$24.2 Billion
Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 81,091 shares of DXCM stock, worth $7.22 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

81,091

Previous 6,731 1104.74%

Holding current value

$7.22 Million

Previous $451,000 1298.23%

% of portfolio

0.03%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$65.68 - $81.01 $4.88 Million - $6.02 Million	74,360 Added 1104.74%	81,091 $6.31 Million
Q3 2024 Nov 04, 2024	SELL	$64.0 - $116.06 $1.82 Million - $3.31 Million	-28,485 Reduced 80.89%	6,731 $451,000
Q2 2024 Aug 05, 2024	SELL	$110.31 - $140.45 $35.5 Million - $45.2 Million	-321,817 Reduced 90.14%	35,216 $3.99 Million
Q1 2024 Apr 05, 2024	BUY	$114.22 - $140.1 $15.7 Million - $19.2 Million	137,336 Added 62.51%	357,033 $49.5 Million
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $5.56 Million - $9.14 Million	-73,643 Reduced 25.1%	219,697 $27.3 Million
Q3 2023 Nov 06, 2023	SELL	$86.06 - $137.93 $62.5 Million - $100 Million	-725,820 Reduced 71.22%	293,340 $27.4 Million
Q2 2023 Aug 03, 2023	BUY	$112.47 - $130.98 $37.3 Million - $43.5 Million	331,983 Added 48.31%	1,019,160 $131 Million
Q1 2023 May 04, 2023	BUY	$104.0 - $122.92 $59.7 Million - $70.6 Million	574,273 Added 508.64%	687,177 $79.8 Million
Q4 2022 Feb 06, 2023	BUY	$84.98 - $122.67 $6.3 Million - $9.09 Million	74,120 Added 191.11%	112,904 $12.8 Million
Q3 2022 Nov 02, 2022	BUY	$76.35 - $94.18 $1.55 Million - $1.91 Million	20,328 Added 110.14%	38,784 $3.12 Million
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $1.11 Million - $2.18 Million	16,373 Added 786.03%	18,456 $1.38 Million
Q1 2022 May 06, 2022	BUY	$94.08 - $130.2 $118,728 - $164,312	1,262 Added 153.71%	2,083 $1.07 Million
Q4 2021 Feb 03, 2022	BUY	$129.87 - $162.82 $40,259 - $50,474	310 Added 60.67%	821 $441,000
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $188,663 - $253,142	-1,768 Reduced 77.58%	511 $279,000
Q2 2021 Aug 05, 2021	SELL	$80.99 - $107.93 $8.71 Million - $11.6 Million	-107,539 Reduced 97.92%	2,279 $973,000
Q1 2021 May 05, 2021	SELL	$84.79 - $104.74 $4.36 Million - $5.39 Million	-51,445 Reduced 31.9%	109,818 $9.87 Million
Q4 2020 Feb 04, 2021	SELL	$78.0 - $104.5 $297,180 - $398,145	-3,810 Reduced 2.31%	161,263 $59.6 Million
Q3 2020 Nov 02, 2020	BUY	$95.51 - $112.95 $2.48 Million - $2.94 Million	26,005 Added 18.7%	165,073 $68 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $1.54 Million - $2.59 Million	24,599 Added 21.49%	139,068 $14.1 Million
Q1 2020 May 04, 2020	BUY	$47.79 - $75.63 $1.11 Million - $1.76 Million	23,310 Added 25.57%	114,469 $30.8 Million
Q4 2019 Feb 07, 2020	BUY	$36.62 - $57.29 $917,660 - $1.44 Million	25,059 Added 37.91%	91,159 $19.9 Million
Q3 2019 Nov 07, 2019	SELL	$35.53 - $43.8 $201,099 - $247,907	-5,660 Reduced 7.89%	66,100 $9.87 Million
Q2 2019 Jul 29, 2019	SELL	$27.84 - $38.92 $766,880 - $1.07 Million	-27,546 Reduced 27.74%	71,760 $10.8 Million
Q1 2019 Apr 25, 2019	SELL	$28.07 - $38.18 $2.14 Million - $2.91 Million	-76,120 Reduced 43.39%	99,306 $11.8 Million
Q4 2018 Feb 11, 2019	SELL	$26.99 - $37.37 $1.04 Million - $1.44 Million	-38,422 Reduced 17.97%	175,426 $21 Million
Q3 2018 Nov 05, 2018	BUY	$23.35 - $36.72 $265,956 - $418,240	11,390 Added 5.63%	213,848 $30.6 Million
Q2 2018 Jul 31, 2018	BUY	$17.54 - $25.22 $3.55 Million - $5.11 Million	202,458 New	202,458 $19.2 Million

Others Institutions Holding DXCM

# of Institutions

1,072

Shares Held

339M

Call Options Held

6.74M

Put Options Held

6.33M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Dexcom Inc Transaction History